P2RX7 can be considered to be a fine tuner of the tumor microenvironment, given that it is able to induce cell proliferation and death as well as to modulate the immune response through various pathways, notably through the release of IL-18 following the activation of the NLRP3 inflammasome. Here, IL18 is linked to neoplasm.